Swoop™ is the brainchild of Hyperfine, a company founded in 2014 by longtime scientist-inventor Dr. Jonathan Rothberg, who developed high-speed DNA sequencing and the world’s best-selling point-of-care ultrasound, the Butterfly iQ.
At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe.
While the Hyperfine team kept the fundamental principles of MRI and its core components, they turned just about everything else about MRI on its head. The team designed for simplicity while leveraging the million-fold improvement in computing power since the first MRI systems were designed over 40 years ago.
Hyperfine produced its first images within a year of the company’s founding, and since then, it has rapidly advanced image quality and functionality.
Today, Swoop™ is the first portable, easy-to-use MRI system in the world.
Meet Our Executive Team
Jonathan Rothberg, PhD
Serial entrepreneur, founded and invented massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip (Butterfly Network); awarded the National Medal of Technology and Innovation by US President Barack Obama; Yale University PhD, MS, MPhil; Carnegie Mellon BS.
Successful CEO, Chairman, board member, entrepreneur, and investor, involved in more than 20 medtech startup, growth, and public companies with market valuations totaling over $20 billion and benefitting over 20 million patients with the therapies and diagnostics they deliver. Ernst & Young Entrepreneur Of The Year. Goldman Sachs 100 Most Intriguing Entrepreneurs. University of Southern California Magna Cum Laude BSBA. Harvard Business School MBA.
President and CEO
Twenty-five years building and leading teams at digital surgery, digital health ecosystem, surgical robotics, and medical imaging and diagnostic startups and Fortune 500 companies, including Apple, Verb Surgical, Abbott Medical Optics, OptiMedica, Intuitive Surgical, Xradia, and Varioscale. Awarded patents in x-ray imaging, medical endoscopy, and laser surgery applications. University of Kansas BS; University of Colorado, Boulder MS.
Chief Operating Officer
20+ years leading R&D and start-ups at Thermo Fisher Scientific, Life Technologies / Ion Torrent, Lucent Technologies / Sycamore Networks / Sirocco Systems, Sahara Networks; experience at Raytheon, GTE, Motorola; University of Rhode Island BS EE / MBA.
Khan Siddiqui, MD
Chief Medical Officer /
Chief Strategy Officer
Serial entrepreneur; board-certified radiologist with leadership experience at Johns Hopkins University and University of Maryland; American College of Radiology Informatics Commission; Microsoft R&D leader; Founder, CTO, and Chief Medical Officer of higi.
Senior Vice President Global /
Twenty-five years sales and marketing experience with healthcare startups and Fortune 500 companies focused on neurosurgical medical and imaging devices. Extensive experience building early stage commercial organizations. Previously, Senior Vice President Global Sales and Marketing at IMRIS, VP Sales and Marketing at Clearpoint Neuro (formerly MRI Interventions), and Medtronic, Regional Sales Director. Ohio State University BSBA.
20-year medical device marketing leader, divisional Chief Marketing Officer at GE Healthcare, VP US Marketing at Medtronic; Vanderbilt University MBA.
Brian Welch, PhD, MBA
Director of Clinical Science
23-year veteran of medical imaging, including Philips Healthcare, Vanderbilt University Medical Center; Mayo Clinic College of Medicine PhD, Tennessee Technological University MBA, University of Southern California BS.
Michael Poole, PhD
Co-founder at Hyperfine and 17 years of MRI development in academia and industry, including fellowships at Forschungszentrum Jülich, University of Queensland, and the Sir Peter Mansfield MR Centre; University of Nottingham PhD.
Hyperfine began from our personal experience with the extraordinary power — and many challenges — of conventional MRI.
Despite being one of the safest and most informative imaging modalities available, MRI is accessible to just a small percentage of patients. Globally, some 4.7 billion people lack access to any form of medical imaging. For MRI, the picture is even bleaker: the World Health Organization estimates that just 10% of the world’s population has access to MRI (2008).
Even in the countries in which it is present, MRI is expensive, complicated, and stressful for the patient.
Our core mission at Hyperfine is to make MRI accessible to every patient, regardless of income or resources. Anytime. Anywhere.
What Others Say
[We] believe that the global MRI market is on the brink of a new era as word of the once ‘mythical’ affordable and portable MRI spreads. With its groundbreaking design, Hyperfine’s portable MRI can extend access to cost-effective imaging and, subsequently, its clinical utility and healthcare value across medical applications, clinical specialties and settings, and geographical regions worldwide.
-Frost & Sullivan, 2020
Awards & Recognition
Fast Company Magazine World Changing Ideas honorable mention in two categories: North America and Health
Hyperfine is part of the 4Catalyzer family of companies. 4Catalyzer is a health technology incubator with facilities in Connecticut, New York City, Palo Alto, and Taiwan. The mission of 4Catalyzer is to make healthcare more accessible and maximize societal impact.